Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Schulz

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Immunology|April 29, 2014
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapyAdam E Snook, Michael S Magee, Stephanie Schulz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2002
Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomachJason Park, Stephanie Schulz, Janis Haaf, et al.
Cancer|September 3, 2011
Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomesTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Journal of Surgical Oncology|January 19, 2012
Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancerTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Histopathology|August 22, 2009
Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasmsVincenzo Ciocca, Alessandro Bombonati, Juan P Palazzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancerTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Journal of Surgical Oncology|March 24, 2012
Molecular staging individualizing cancer managementAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Expert Review of Molecular Diagnostics|November 10, 2009
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Advances in Clinical Chemistry|February 1, 2011
Molecular staging estimates occult tumor burden in colorectal cancerAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Biochemistry|March 6, 2002
Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calciumShiva Kazerounian, Giovanni M Pitari, Inez Ruiz-Stewart, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|April 29, 2014
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapyAdam E Snook, Michael S Magee, Stephanie Schulz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2002
Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomachJason Park, Stephanie Schulz, Janis Haaf, et al.
Cancer|September 3, 2011
Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomesTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Journal of Surgical Oncology|January 19, 2012
Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancerTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Histopathology|August 22, 2009
Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasmsVincenzo Ciocca, Alessandro Bombonati, Juan P Palazzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancerTerry Hyslop, David S Weinberg, Stephanie Schulz, et al.
Journal of Surgical Oncology|March 24, 2012
Molecular staging individualizing cancer managementAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Expert Review of Molecular Diagnostics|November 10, 2009
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Advances in Clinical Chemistry|February 1, 2011
Molecular staging estimates occult tumor burden in colorectal cancerAlex Mejia, Stephanie Schulz, Terry Hyslop, et al.
Biochemistry|March 6, 2002
Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calciumShiva Kazerounian, Giovanni M Pitari, Inez Ruiz-Stewart, et al.
Pageof 7